Possible Use of Linear Echobronchoscope for Diagnosis of Peripheral Pulmonary Nodules.

EBUS-TBNA linear echobronchoscope peripheral pulmonary nodule transbronchial approach to pulmonary nodules transbronchial needle aspiration

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
17 Jul 2023
Historique:
received: 28 03 2023
revised: 27 04 2023
accepted: 27 04 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Echobronchoscope-guided transbronchial needle aspiration (EBUS-TBNA) is mainly used as the transbronchial approach to hilar/mediastinal lymph nodes or lesions, for diagnostic or staging purposes. Moreover, the role of linear EBUS-TBNA as a diagnostic tool for central intrapulmonary lesions adjacent to the trachea or the major bronchi is also well established. However, since the tip of the ultrasound probe at the distal end of the echobronchoscope is very thin, it can be wedged through smaller peripheral bronchi, reaching the distal parenchyma and allowing for peripheral pulmonary lesion sampling. The main aim of this retrospective study was to evaluate the diagnostic yield and the safety of EBUS-TBNA in the diagnosis of pulmonary peripheral nodules. The database of the Interventional Pulmonology Unit of Azienda Ospedaliero-Universitaria delle Marche (Ancona, Italy) was evaluated to identify peripheral pulmonary nodules approached by EBUS-TBNA. Thirty patients with a single peripheral pulmonary nodule located peripherally to the subsegmental bronchi of the lower lobes and adjacent to a small bronchus greater than 3 mm in diameter were included in this study. The nodule was visible using endoscopic ultrasound in 28 patients and the diagnosis was obtained via EBUS-TBNA in 26 cases (12 adenocarcinoma, 5 typical carcinoid tumors, 4 hamartoma and 5 metastatic lesions). The diagnostic yield was 86.6% for all 30 patients and 92.8% if only the 28 patients in which the lesion was visualized via echobronchoscopy were considered. No relevant adverse events were observed. We conclude that EBUS-TBNA may be an effective and safe option to sample pulmonary peripheral nodules in selected patients with lower lobe peripheral pulmonary lesions adjacent to small bronchi greater than 3 mm in diameter and reachable with the EBUS-TBNA probe.

Identifiants

pubmed: 37510137
pii: diagnostics13142393
doi: 10.3390/diagnostics13142393
pmc: PMC10378167
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

BMC Pulm Med. 2018 Aug 13;18(1):137
pubmed: 30103727
N Engl J Med. 2013 May 23;368(21):1980-91
pubmed: 23697514
Lung Cancer. 2005 Dec;50(3):347-54
pubmed: 16171897
Respiration. 2019;98(2):142-150
pubmed: 31352444
Chest. 2020 Oct;158(4):1753-1769
pubmed: 32450240
J Thorac Dis. 2018 Dec;10(12):6950-6959
pubmed: 30746241
Diagnostics (Basel). 2021 Aug 15;11(8):
pubmed: 34441413
Front Med (Lausanne). 2023 Jan 12;9:1087028
pubmed: 36714142
Respiration. 2014;87(2):165-76
pubmed: 24401166
Lung Cancer. 2019 Aug;134:194-201
pubmed: 31319981
Respiration. 2022;101(9):814-815
pubmed: 35793645
J Thorac Dis. 2015 May;7(5):799-809
pubmed: 26101635
Respiration. 2022;101(8):775-783
pubmed: 35483329
Lung Cancer. 2009 Jan;63(1):45-9
pubmed: 18514365
Curr Opin Pulm Med. 2022 Jan 1;28(1):31-36
pubmed: 34750298
Thorax. 2006 Sep;61(9):795-8
pubmed: 16738038
J Thorac Oncol. 2008 Sep;3(9):985-8
pubmed: 18758300
Respirology. 2017 Apr;22(3):443-453
pubmed: 28177181
Respiration. 2019;98(4):321-328
pubmed: 31121593
Eur Respir J. 2011 Apr;37(4):902-10
pubmed: 20693253
Chest. 2023 Jun;163(6):1589-1598
pubmed: 36640994
Endosc Ultrasound. 2013 Apr;2(2):96-101
pubmed: 24949372
Eur Respir J. 2002 Oct;20(4):972-4
pubmed: 12412691
Chest. 2021 Feb;159(2):845-852
pubmed: 32822675
Ann Thorac Med. 2013 Jan;8(1):14-21
pubmed: 23439919
Chest. 2004 Sep;126(3):959-65
pubmed: 15364779
Transl Lung Cancer Res. 2017 Feb;6(1):23-34
pubmed: 28331821
Ann Transl Med. 2019 Aug;7(15):348
pubmed: 31516894
Respiration. 2014;88(5):430-40
pubmed: 25402610
Chest. 2020 Apr;157(4):994-1011
pubmed: 31738928
Adv Respir Med. 2023 Jan 12;91(1):1-8
pubmed: 36648877
J Bronchology Interv Pulmonol. 2018 Oct;25(4):274-282
pubmed: 30179922

Auteurs

Lina Zuccatosta (L)

Pulmonary Diseases Unit, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.

Francesca Gonnelli (F)

Pulmonary Diseases Unit, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.

Gianmarco Gasparini (G)

Department of Biomedical Sciences and Public Health, Polytechnic University of Marche Region, 60126 Ancona, Italy.

Arianna Duro (A)

Department of Biomedical Sciences and Public Health, Polytechnic University of Marche Region, 60126 Ancona, Italy.

Francesca Barbisan (F)

Pathological Anatomy Institute, Polytechnic University of Marche Region, 60126 Ancona, Italy.

Gaia Goteri (G)

Pathological Anatomy Institute, Polytechnic University of Marche Region, 60126 Ancona, Italy.

Giulia Veronesi (G)

School of Medicine and Surgery, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Department of Thoracic Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

Rocco Trisolini (R)

Interventional Pulmonology Unit, Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.

Stefano Gasparini (S)

Pulmonary Diseases Unit, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.

Classifications MeSH